Evoke Wealth’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $556K | Sell |
1,370
-96
| -7% | -$39K | 0.01% | 318 |
|
|
2025
Q1 | $730K | Buy |
1,466
+287
| +24% | +$143K | 0.02% | 226 |
|
|
2024
Q4 | $614K | Sell |
1,179
-41
| -3% | -$21.4K | 0.02% | 233 |
|
|
2024
Q3 | $755K | Buy |
+1,220
| New | +$755K | 0.02% | 205 |
|
|
2024
Q2 | – | Sell |
-1,157
| Closed | -$673K | – | 353 |
|
|
2024
Q1 | $673K | Buy |
+1,157
| New | +$673K | 0.02% | 209 |
|
|
2023
Q4 | – | Sell |
-1,116
| Closed | -$565K | – | 321 |
|
|
2023
Q3 | $565K | Buy |
1,116
+177
| +19% | +$89.7K | 0.02% | 223 |
|
|
2023
Q2 | $490K | Buy |
939
+215
| +30% | +$112K | 0.02% | 222 |
|
|
2023
Q1 | $418K | Sell |
724
-74
| -9% | -$42.7K | 0.02% | 232 |
|
|
2022
Q4 | $440K | Sell |
798
-276
| -26% | -$152K | 0.02% | 228 |
|
|
2022
Q3 | $545K | Sell |
1,074
-123
| -10% | -$62.4K | 0.02% | 203 |
|
|
2022
Q2 | $651K | Sell |
1,197
-563
| -32% | -$306K | 0.02% | 198 |
|
|
2022
Q1 | $1.04M | Buy |
1,760
+203
| +13% | +$120K | 0.03% | 174 |
|
|
2021
Q4 | $1.04M | Buy |
1,557
+27
| +2% | +$18K | 0.03% | 176 |
|
|
2021
Q3 | $874K | Sell |
1,530
-90
| -6% | -$51.4K | 0.03% | 181 |
|
|
2021
Q2 | $818K | Buy |
1,620
+216
| +15% | +$109K | 0.03% | 192 |
|
|
2021
Q1 | $641K | Buy |
1,404
+723
| +106% | +$330K | 0.03% | 192 |
|
|
2020
Q4 | $317K | Buy |
681
+510
| +298% | +$237K | 0.02% | 191 |
|
|
2020
Q3 | $76K | Buy |
171
+55
| +47% | +$24.4K | 0.01% | 313 |
|
|
2020
Q2 | $42K | Sell |
116
-8
| -6% | -$2.9K | ﹤0.01% | 368 |
|
|
2020
Q1 | $35.2K | Sell |
124
-256
| -67% | -$72.7K | 0.01% | 372 |
|
|
2019
Q4 | $124K | Buy |
380
+139
| +58% | +$45.2K | 0.02% | 297 |
|
|
2019
Q3 | $70.2K | Buy |
+241
| New | +$70.2K | 0.01% | 421 |
|